Events for December 14, 2018

This live activity will review newly approved and investigational agents and combinations of agents that may improve outcomes for patients with relapsed, refractory follicular lymphoma (FL). Traditionally, FL has been associated with the development of aggressive disease and poor outcomes for many patients. The ongoing development of new compounds with unique mechanisms of action extends the available treatment options for patients across all lines of therapy, with an emphasis on personalization of care.

This case-based live activity will cover the treatment and management of patients with multiple sclerosis (MS).

This case-based live activity will cover the treatment and management of patients with diabetes.